Accuracy of routinely collected hospital administrative discharge data and death certificate ICD-10 diagnostic coding in progressive supranuclear palsy and corticobasal syndrome: a systematic review and validation study Diane M. A. SwallowCarl E. Counsell Original Communication Open access 12 April 2024 Pages: 2929 - 2937
TMS of the left primary motor cortex improves tremor intensity and postural control in primary orthostatic tremor Florian SchoeberlJames DowsettAndreas Zwergal Original Communication Open access 16 April 2024 Pages: 2938 - 2947
Pallidal deep brain stimulation for patients with myoclonus-dystonia without SGCE mutations Jun IkezawaFusako YokochiKazushi Takahashi Short Commentary 04 April 2024 Pages: 2948 - 2954
Advancing understanding and treatment of spinal muscular atrophy with four SMN2 copies: a critical review Burhanuddin Sohail RangwalaHussain Sohail Rangwala Letter to the Editors 04 March 2024 Pages: 2955 - 2956
The motor band sign differentiates hereditary spastic paraplegia from the others upper motor neuron syndromes Graziella DonatelliFrancesca BianchiMirco Cosottini Letter to the Editors 08 April 2024 Pages: 2957 - 2959
Clinical treatment of cryptococcal meningitis: an evidence-based review on the emerging clinical data Mao-Zhu LiuXin-Hua DaiEn-Qiang Chen Review 30 January 2024 Pages: 2960 - 2979
Predictors of early neurological deterioration in patients with intracerebral hemorrhage: a systematic review and meta-analysis Wei ZhuJiehong ZhouChaofeng Fan Review 20 March 2024 Pages: 2980 - 2991
Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies Felix LangerscheidtTamara WiedHans Zempel Review Open access 30 March 2024 Pages: 2992 - 3018
Soccer (football) and brain health Umberto PensatoPietro Cortelli Review Open access 01 April 2024 Pages: 3019 - 3029
Ticagrelor versus clopidogrel in dual antiplatelet therapy after minor stroke or transient ischemic attack: an updated network meta-analysis Gabriel MarinheiroBeatriz AraújoJoão Paulo Mota Telles Review 05 April 2024 Pages: 3030 - 3038
Endovascular thrombectomy with versus without intravenous thrombolysis in patients with acute basilar artery occlusion: a systematic review and meta-analysis Lingyu CaiLiaoyuan WangZhao Dai Review 10 April 2024 Pages: 3039 - 3049
Exosomes for neurodegenerative diseases: diagnosis and targeted therapy Hui TaoBo Gao Review 12 April 2024 Pages: 3050 - 3062
Channelopathies in epilepsy: an overview of clinical presentations, pathogenic mechanisms, and therapeutic insights Andy Cheuk-Him NgMohamed ChahineJuan P. Appendino Review 12 April 2024 Pages: 3063 - 3094
The role of language-related functional brain regions and white matter tracts in network plasticity of post-stroke aphasia Yue HanYuanyuan JingFang Deng Review 12 April 2024 Pages: 3095 - 3115
Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption Barry A. SingerJenny FengHoracio Chiong-Rivero Review Open access 14 April 2024 Pages: 3116 - 3130
Clinical trial evidence of quality-of-life effects of disease-modifying therapies for multiple sclerosis: a systematic analysis Julian HirtKinga DembowskaPerrine Janiaud Review Open access 16 April 2024 Pages: 3131 - 3141
Early intensive versus escalation treatment in patients with relapsing–remitting multiple sclerosis in Austria Michael GugerChristian EnzingerAustrian MS Treatment Registry (AMSTR) Original Communication Open access 02 March 2024 Pages: 3142 - 3152
Outcome predictors of post-COVID conditions in the European Academy of Neurology COVID-19 registry Maurizio Angelo LeoneRaimund Helbokthe ENERGY Study Group (§) Original Communication 04 March 2024 Pages: 3153 - 3168
Effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by comorbidities and etiology in the real world: 12-month subgroup data from the international EXPERIENCE pooled analysis Jerzy P. SzaflarskiHervé BessonVicente Villanueva Original Communication Open access 04 March 2024 Pages: 3169 - 3185
Quantitative whole-body muscle MRI in idiopathic inflammatory myopathies including polymyositis with mitochondrial pathology: indications for a disease spectrum Lea-Katharina ZiererSteffen NaegelAlexander Mensch Original Communication Open access 05 March 2024 Pages: 3186 - 3202
The cognitive relevance of non-lesional damage to cortical networks in people with multiple sclerosis Eva A. KrijnenTommy A. A. BroedersMenno M. Schoonheim Original Communication Open access 05 March 2024 Pages: 3203 - 3214
Symptoms and signs did not predict outcome after surgery: a prospective study of 143 patients with idiopathic normal pressure hydrocephalus Kerstin AndrénCarsten WikkelsøMats Tullberg Original Communication Open access 05 March 2024 Pages: 3215 - 3226
Visual and vestibular motion perception in persistent postural-perceptual dizziness (PPPD) Renana StormJanina KrauseAndreas Sprenger Original Communication Open access 05 March 2024 Pages: 3227 - 3238
Supra- and infra-tentorial degeneration patterns in primary lateral sclerosis: a multimodal longitudinal neuroradiology study Jana KleinerovaMarlene TahedlPeter Bede Original Communication Open access 05 March 2024 Pages: 3239 - 3255
Sex impacts treatment decisions in multiple sclerosis Harald HegenKlaus BerekFranziska Di Pauli Original Communication Open access 05 March 2024 Pages: 3256 - 3267
Evaluation of a self-administered iPad®-based processing speed assessment for people with multiple sclerosis in a clinical routine setting Stefanie HechenbergerBirgit HelmlingerDaniela Pinter Original Communication Open access 05 March 2024 Pages: 3268 - 3278
Neurological autoimmunity in melanoma patients: a comparison between those exposed and non-exposed to immune checkpoint inhibitors Andreu VilasecaAntonio FarinaBastien Joubert Original Communication 11 March 2024 Pages: 3279 - 3290
Executive functions in patients with bilateral and unilateral peripheral vestibular dysfunction Corina G. SchöneDominique VibertFred W. Mast Original Communication Open access 11 March 2024 Pages: 3291 - 3308
Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study Ruth GeraldesMonica Santosthe DCVAS Study Group Original Communication Open access 12 March 2024 Pages: 3309 - 3320
Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial Xue TianQin XuAnxin Wang Original Communication 12 March 2024 Pages: 3321 - 3327
Moyamoya disease in Southeast Asians: genetic and autopsy data, new cases, systematic review, and meta-analysis of all patients from the literature Daniel StrunkPeter BauerMarkus Kraemer Original Communication Open access 13 March 2024 Pages: 3328 - 3339
Marked increase in severe neurological disorders after nitrous oxide abuse: a retrospective study in the Greater Paris area Yachar DawudiLoris AzoyanMickael Bonnan Original Communication Open access 13 March 2024 Pages: 3340 - 3346
Sex differences in modifiable risk factors for stroke incidence and recurrence: the UCC-SMART study Ina RissanenMaartje BastenFor the UCC-SMART-Study Group Original Communication Open access 16 March 2024 Pages: 3347 - 3358
Dysautonomia in anti-Hu paraneoplastic neurological syndromes Macarena Villagrán-GarcíaAntonio FarinaJérôme Honnorat Original Communication 17 March 2024 Pages: 3359 - 3369
Corneal nerves and amyotrophic lateral sclerosis: an in vivo corneal confocal imaging study Raoul K. KhannaSophie CatanesePhilippe Corcia Original Communication 18 March 2024 Pages: 3370 - 3377
Thalamic nuclei volume partially mediates the effects of aerobic capacity on fatigue in people with multiple sclerosis Matteo AlbergoniElisabetta PaganiMassimo Filippi Original Communication 20 March 2024 Pages: 3378 - 3388
Follow-up infarct volume on fluid attenuated inversion recovery (FLAIR) imaging in distal medium vessel occlusions: the role of cerebral blood volume index Hamza SalimDhairya A. LakhaniVivek Yedavalli Original Communication 20 March 2024 Pages: 3389 - 3397
Prevalence and temporal relationship of clinical co-morbidities in idiopathic dystonia: a UK linkage-based study Grace A. BaileyAnna RawlingsKathryn J. Peall Original Communication Open access 21 March 2024 Pages: 3398 - 3408
Persons with multiple sclerosis older than 55 years: an analysis from the German MS registry Yasemin GoereciDavid EllenbergerClemens Warnke Original Communication Open access 22 March 2024 Pages: 3409 - 3416
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues Vera BattiniMaria Antonietta BarbieriMaurizio Sessa Original Communication Open access 22 March 2024 Pages: 3417 - 3425
Machine learning models help differentiate between causes of recurrent spontaneous vertigo Chao WangAllison S. YoungMiriam S. Welgampola Original Communication 23 March 2024 Pages: 3426 - 3438
Exploring mitochondrial biomarkers for Friedreich's ataxia: a multifaceted approach Lucie StovickovaHana HansikovaAlena Zumrova Original Communication Open access 23 March 2024 Pages: 3439 - 3454
Determinants of self-perceived quality of life in mildly disabled multiple sclerosis patients: a cross-sectional study Silvy PilottoMatteo FlorisIgnazio Roberto Zarbo Original Communication 25 March 2024 Pages: 3455 - 3461
Real-World experience with efgartigimod in patients with myasthenia gravis Lior FuchsShahar ShellyArnon Karni Original Communication 25 March 2024 Pages: 3462 - 3470
Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy Tomoo SatoMasahiro NagaiYoshihisa Yamano Original Communication Open access 02 March 2024 Pages: 3471 - 3485
Impaired vestibular function associated with orthostatic hypotension in patients with multiple system atrophy Xue WangShanshan MeiPiu Chan Original Communication 25 March 2024 Pages: 3486 - 3495
Early prediction of unfavorable evolution after a first clinical episode suggestive of multiple sclerosis: the EUMUS score Giulia MallucciOttavia Eleonora FerraroRoberto Bergamaschi Original Communication 26 March 2024 Pages: 3496 - 3505
Efgartigimod in the treatment of Guillain–Barré syndrome Huiqiu ZhangJing MaWei Zhang Original Communication 26 March 2024 Pages: 3506 - 3511
Matching proposed clinical and MRI criteria of aggressive multiple sclerosis to serum and cerebrospinal fluid markers of neuroaxonal and glial injury Martin A. Schaller-PauleMichelle MaiwormChristian Foerch Original Communication Open access 27 March 2024 Pages: 3512 - 3526
Vestibular-evoked myogenic potential abnormalities in Parkinson’s disease with freezing of gait Yuhan JiangMengxi ZhouWei Chen Original Communication 27 March 2024 Pages: 3527 - 3536
